Vestmark Advisory Solutions’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.7M | Buy |
53,968
+2,425
| +5% | +$2.48M | 0.61% | 26 |
|
|
2026
Q1 | $47.4M | Buy |
51,543
+17,781
| +53% | +$18M | 0.53% | 35 |
|
|
2025
Q4 | $36.3M | Buy |
33,762
+16,217
| +92% | +$15.5M | 0.49% | 35 |
|
|
2025
Q3 | $13.4M | Buy |
17,545
+4,400
| +33% | +$3.27M | 0.26% | 89 |
|
|
2025
Q2 | $10.2M | Sell |
13,145
-10,557
| -45% | -$8.2M | 0.15% | 115 |
|
|
2025
Q1 | $19.6M | Buy |
23,702
+11,591
| +96% | +$9.6M | 0.5% | 39 |
|
|
2024
Q4 | $9.35M | Buy |
12,111
+1,332
| +12% | +$1.1M | 0.32% | 64 |
|
|
2024
Q3 | $9.5M | Buy |
10,779
+692
| +7% | +$622K | 0.36% | 57 |
|
|
2024
Q2 | $9.13M | Sell |
10,087
-811
| -7% | -$649K | 0.38% | 55 |
|
|
2024
Q1 | $8.48M | Sell |
10,898
-310
| -3% | -$221K | 0.37% | 61 |
|
|
2023
Q4 | $6.53M | Sell |
11,208
-475
| -4% | -$277K | 0.33% | 70 |
|
|
2023
Q3 | $6.28M | Sell |
11,683
-8,588
| -42% | -$4.43M | 0.46% | 42 |
|
|
2023
Q2 | $9.5M | Buy |
20,271
+971
| +5% | +$407K | 0.36% | 61 |
|
|
2023
Q1 | $6.63M | Buy |
19,300
+2,181
| +13% | +$736K | 0.29% | 87 |
|
|
2022
Q4 | $6.26M | Buy |
17,119
+534
| +3% | +$189K | 0.31% | 65 |
|
|
2022
Q3 | $5.36M | Sell |
16,585
-107
| -0.6% | -$33.9K | 0.3% | 76 |
|
|
2022
Q2 | $5.41M | Buy |
16,692
+3,988
| +31% | +$1.2M | 0.31% | 71 |
|
|
2022
Q1 | $3.64M | Buy |
12,704
+547
| +4% | +$141K | 0.21% | 111 |
|
|
2021
Q4 | $3.36M | Buy |
12,157
+364
| +3% | +$92.3K | 0.19% | 121 |
|
|
2021
Q3 | $2.72M | Buy |
11,793
+1,869
| +19% | +$461K | 0.18% | 136 |
|
|
2021
Q2 | $2.28M | Buy |
9,924
+592
| +6% | +$119K | 0.16% | 158 |
|
|
2021
Q1 | $1.74M | Buy |
9,332
+585
| +7% | +$114K | 0.15% | 185 |
|
|
2020
Q4 | $1.48M | Buy |
8,747
+489
| +6% | +$73K | 0.17% | 171 |
|
|
2020
Q3 | $1.22M | Sell |
8,258
-1,541
| -16% | -$238K | 0.16% | 179 |
|
|
2020
Q2 | $1.61M | Buy |
9,799
+127
| +1% | +$19.5K | 0.25% | 122 |
|
|
2020
Q1 | $1.34M | Sell |
9,672
-729
| -7% | -$100K | 0.26% | 113 |
|
|
2019
Q4 | $1.37M | Sell |
10,401
-1,521
| -13% | -$176K | 0.28% | 129 |
|
|
2019
Q3 | $1.33M | Buy |
11,922
+2,216
| +23% | +$247K | 0.22% | 146 |
|
|
2019
Q2 | $1.08M | Sell |
9,706
-1,434
| -13% | -$169K | 0.18% | 166 |
|
|
2019
Q1 | $1.45M | Buy |
+11,140
| New | +$1.35M | 0.26% | 119 |
|
Other funds holding LLY
Vestmark Advisory Solutions's LLY Position: Q2 2026 in Review
Vestmark Advisory Solutions increased its Eli Lilly (LLY) stake by 4.7% in Q2 2026, buying an estimated $2.48M and bringing the position to 53,968 shares worth $64.7M. The position accounts for 0.61% of the portfolio, ranked #26.
Vestmark Advisory Solutions first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. 4,650 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vestmark Advisory Solutions held 53,968 shares of Eli Lilly worth $64.7M as of Q2 2026.
- Vestmark Advisory Solutions bought 2,425 Eli Lilly shares in Q2 2026, an estimated $2.48M.
- Eli Lilly made up 0.61% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #26 holding.
- Vestmark Advisory Solutions first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
- 4,650 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.